Severe flare as a predictor of poor outcome in ankylosing spondylitis: A cohort study using questionnaire and routine data linkage

Rheumatology (United Kingdom)

Volumn 54, Issue 9, 2015, Pages 1563-1572

  Cooksey, Roxanne ^a   Brophy, Sinead ^a   Dennis, Michael ^a   Davies, Helen ^a   Atkinson, Mark ^a   Irvine, Elizabeth ^a   Siebert, Stefan ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ankylosing spondylitis; Disease flare; Outcome measures; Spondyloarthritis

Indexed keywords

ABSENTEEISM; ADULT; ANKYLOSING SPONDYLITIS; ANXIETY; ARTICLE; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; ROSENBERG SELF-ESTEEM SCALE; SELF ESTEEM; SELF REPORT; SEVERE FLARE; SEX DIFFERENCE; THEMATIC ANALYSIS; TIME MANAGEMENT;

EID: 84943222885     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev015     Document Type: Article

References (47)

1. Martindale J, Smith J, Sutton CJ et al. Disease and psychological status in ankylosing spondylitis. Rheumatology 2006;45:1288-93.
2. Cooksey R, Brophy S, Gravenor MB et al. Frequency and characteristics of disease flares in ankylosing spondylitis. Rheumatology 2010;49:929-32.
3. Stone MA, Pomeroy E, Keat A et al. Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Rheumatology 2008;47: 1213-8.
4. Brophy S, Calin A. Definition of disease flare in ankylosing spondylitis: the patients' perspective. J Rheumatol 2002; 29:954-8.
5. FitzGerald JD, Grossman JM. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 1999;8: 638-44.
6. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937-44.
7. Chan RW, Lai FM, Li EK et al. Expression of T-bet, a type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare. Rheumatology 2007; 46:44-8.
8. Molnar-Kimber KL, Kimber CT. Each type of cause that initiates rheumatoid arthritis or RA flares differentially affects the response to therapy. Med Hypotheses 2012;78: 123-9.
9. Bennett AN, McGonagle D, O'Connor P et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58: 3413-8.
10. Calin A, Nakache JP, Gueguen A et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999;38: 878-82.
11. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997; 36:766-71.
12. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
13. Selvaag AM, Lien G, Sorskaar D et al. Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study. J Rheumatol 2005;32:1122-30.
14. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology 2004;43: 1565-8.
15. Doran MF, Brophy S, MacKay K, Taylor G, Calin A. Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 2003;30:316-20.
16. Braun J, Pincus T. Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 2002;20(6 Suppl 28):S16-22.
17. Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002;29: 1236-43.
18. Kaan U, Ferda O. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 2005;25:357-60.
19. Falkenbach A, Franke A, van der Linden S. Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2003;30:2186-92.
20. Atkinson MD, Brophy S, Siebert S et al. Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales. BMC Musculoskelet Disord 2010;11:197.
21. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
22. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
23. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003;1:29.
24. Lerner D, Amick BC 3rd, Rogers WH et al. The Work Limitations Questionnaire. Med Care 2001;39:72-85.
25. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65.
26. Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton University Press, 1965.
27. Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology 2010;49:812-9.
28. Packham JC, Jordan KP, Haywood KL, Garratt AM, Healey EL. Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure. Rheumatology 2012;51:707-14.
29. Baysal O, Durmus B, Ersoy Y et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 2011;31:795-800.
30. Jang JH, Green CE, Assassi S et al. The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology 2011; 50:2087-92.
31. Aissaoui N, Rostom S, Hakkou J et al. Fatigue in patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status, and sleep disturbance. Rheumatol Int 2012;32:2117-24.
32. Brophy S, Cooksey R, Davies H et al. The effect of physical activity and motivation on function in ankylosing spondylitis: a cohort study. Semin Arthritis Rheum 2013; 42:619-26.
33. Jorge RT, Brumini C, Jones A, Natour J. Body image in patients with rheumatoid arthritis. Mod Rheumatol 2010; 20:491-5.
34. Sheasby JE, Barlow JH, Cullen LA, Wright CC. Psychometric properties of the Rosenberg Self-esteem Scale among people with arthritis. Psychol Rep 2000;86(3 Pt 2):1139-46.
35. Ford DV, Jones KH, Verplancke JP et al. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res 2009;9:157.
36. Smyth R. Depression in physical illness. J R Coll Physicians Edinb 2009;39:337-42.
37. Braam AW, Prince MJ, Beekman AT et al. Physical health and depressive symptoms in older Europeans. Results from EURODEP. Br J Psychiatry 2005;187:35-42.
38. Meltzer H, Bebbington P, Brugha T et al. Physical ill health, disability, dependence and depression: results from the 2007 national survey of psychiatric morbidity among adults in England. Disabil Health J 2012;52: 102-10.
39. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
40. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
41. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res 2004;57:35-43.
42. Dissanayake RK, Bertouch JV. Psychosocial interventions as adjunct therapy for patients with rheumatoid arthritis: a systematic review. Int J Rheum Dis 2010;13:324-34.
43. Hewlett S, Sanderson T, May J et al. 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count-an international patient perspective on flare where medical help is sought. Rheumatology 2012;51: 69-76.
44. Vliet Vlieland TP, Li LC. Rehabilitation in rheumatoid arthritis and ankylosing spondylitis: differences and similarities. Clin Exp Rheumatol 2009;27(4 Suppl 55):S171-8.
45. van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology 2012;51(8): 1388-96.
46. van der Heijde D, Lie E, Kvien TK et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68:1811-8.
47. Lukas C, Landewe R, Sieper J et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68: 18-24.